Anthera hits another setback as its Japanese partner quits on blisibimod

Damian Garde

Pharmaceuticals is back on the hunt for a in Asia after drugmaker Zenyaku pulled the plug on the pair's collaboration, clouding the future for the company's lupus drug.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS